Skip to main content
. 2023 Mar 10;280(7):3375–3382. doi: 10.1007/s00405-023-07913-1

Table 1.

Clinical parameters of the study population

Variable All (n = 308) AHTN (n = 112) DM (n = 40) ASVD (n = 42) AHTN/DM/ASVD (n = 151)
Sex (n)***
Male 163 (52.9%) 58 (51.8%) 26 (65.0%) 32 (76.2%) 87 (57.6%)
Female 145 (47.1%) 54 (48.2%) 14 (35.0%) 10 (23.8%) 64 (42.4%)
Age (years)*,**,***,**** 64.0 (18.0) 67.0 (17.0) 69.0 (15.0) 66.5 (18.0) 67.0 (17.0)
BMI (kg/m2)*,**,**** 24.3 (6.5) 25.9 (6.6) 27.8 (7.2) 25.2 (6.9) 25.9 (6.7)
ASA (n)***
1 + 2 162 (52.6%) 54 (48.2%) 17 (42.5%) 14 (33.3%) 71 (47.0%)
3 + 4 146 (47.4%) 58 (51.8%) 23 (57.5%) 28 (66.7%) 80 (53.0%)
Flap type (n)
RFFF 151 (49.0%) 60 (53.6%) 19 (47.5%) 18 (42.9%) 78 (51.7%)
ALTF 122 (39.6%) 40 (35.7%) 19 (47.5%) 20 (47.6%) 60 (39.7%)
FFF 35 (11.4%) 12 (10.7%) 2 (5.0%) 4 (9.5%) 13 (8.6%)
Flap location (n)
Tongue 45 (14.6%) 16 (14.3%) 7 (17.5%) 6 (14.3%) 23 (15.2%)
Floor of mouth 64 (20.8%) 22 (19.6%) 7 (17.5%) 11 (26.2%) 28 (18.5%)
Mandible 77 (25.0%) 28 (25.0%) 13 (32.5%) 11 (26.2%) 39 (25.8%)
Maxilla + hard palate 39 (12.7%) 14 (12.5%) 5 (12.5%) 1 (2.4%) 16 (10.6%)
Cheek 24 (7.8%) 8 (7.1%) 3 (7.5%) 7 (16.7%) 17 (11.3%)
Soft palate 15 (4.9%) 7 (6.3%) 1 (2.5%) 0 (0.0%) 7 (4.6%)
Extraoral 44 (14.3%) 17 (15.2%) 4 (10.0%) 6 (14.3%) 21 (13.9%)
Recipient vessel (n)
External carotid artery 16 (5.2%) 5 (4.5%) 1 (2.5%) 4 (9.5%) 8 (5.3%)
Facial artery 120 (39.0%) 41 (36.6%) 17 (42.5%) 20 (47.6%) 60 (39.7%)
Lingual artery 15 (4.9%) 4 (3.6%) 2 (5.0%) 2 (4.8%) 5 (3.3%)
Superior thyroid artery 147 (47.7%) 59 (52.7%) 20 (50.0%) 16 (38.1%) 75 (49.7%)
Other 10 (3.2%) 3 (2.7%) 0 (0.0%) 0 (0.0%) 3 (2.0%)
Surgery duration (min) 545.0 (155.0) 547.5 (158.0) 550.5 (140.0) 539.5 (182.0) 545.0 (153.0)
Flap ischemia duration (min) 105.5 (34.0) 109.0 (38.0) 99.0 (31.0) 101.5 (26.0) 107.0 (36.0)
Smoking status (n)
No 182 (59.1%) 66 (58.9%) 27 (67.5%) 25 (59.5%) 93 (61.6%)
Yes 126 (40.9%) 46 (41.1%) 13 (32.5%) 17 (40.5%) 58 (38.4%)
Prior neck dissection (n)
No 249 (80.8%) 97 (86.6%) 35 (87.5%) 35 (83.3%) 127 (84.1%)
Yes 59 (19.2%) 15 (13.4%) 5 (12.5%) 7 (16.7%) 24 (15.9%)
Prior neck irradiation (n)***
No 277 (89.9%) 100 (89.3%) 34 (85.0%) 34 (81.0%) 132 (87.4%)
Yes 31 (10.1%) 12 (10.7%) 6 (15.0%) 8 (19.0%) 19 (12.6%)

Parameters are indicated as numbers (with percentage) for categorical data (sex, ASA, flap type, flap location, recipient vessel, smoking status, prior neck dissection, prior neck irradiation) or median (with interquartile range) for metric data (age, BMI, surgery duration, flap ischemia duration) (separately described for all patients (All), for patients with arterial hypertension (AHTN), for patients with diabetes mellitus (DM), for patients with atherosclerotic vascular disease (ASVD), and for patients with arterial hypertension, diabetes mellitus and or atherosclerotic vascular disease (AHTN/DM/ASVD)); testing for differences between groups with Chi-squared test (sex, ASA, flap type, smoking status, prior neck irradiation), Fisher’s exact test (prior neck dissection), Freeman–Halton test (flap location, recipient vessel) or Mann–Whitney test (age, BMI, surgery duration, flap ischemia duration): *p < 0.05 testing patients with AHTN vs. patients without AHTN; **p < 0.05 testing patients with DM vs. patients without DM; ***p < 0.05 testing patients with ASVD vs. patients without ASVD; ****p < 0.05 testing patients with AHTN/DM/ASVD vs. patients without AHTN/DM/ASVD

AHTN arterial hypertension, DM diabetes mellitus, ASVD atherosclerotic vascular disease, BMI body mass index, ASA American Society of Anesthesiologists score, RFFF radial free forearm flap, ALTF anterolateral thigh flap, FFF fibula free flap